Transcode Therapeutics Inc (RNAZ) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Transcode Therapeutics Inc   (NASDAQ: RNAZ)

Transcode Therapeutics Inc

Officers & Directors


Thomas A. Fitzgerald
Director, Interim Chief Executive Officer and Chief Financial Officer - (Principal Executive Officer and Principal Financial and Accounting Officer)

Erik Manting
Director

Philippe P. Calais
Director, Executive Chairman

Magda Marquet
Director, PhD ,

Transcode Therapeutics Inc currently has 12 employees.






RNAZ Management Effectiveness RNAZ Revenue per Employee RNAZ Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.